Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Deciphering Hematopoietic Reconstitution Dynamics of Lentiviral Vector HBB T87Q -Engineered Hematopoietic Stem Cells Gene Therapy for β-Thalassemia Patients

Ruonan Li, Zhen Gao, Yucan Shen, Lele Zhang, Ke Huang, Hong Pan, Weiwang Li, Linzhu Tian, Jingyu Zhao, Liyun Li, Xiao Yu, Jing Xu, Chun Xu, Yanjie Liu, Weiwei Wang, Zhexiang Kuang, Weiping Yuan, Jun Shi

Blood (2024) 144 (Supplement 1): 4961.

https://doi.org/10.1182/blood-2024-206482

Published: 2024

Journal Articles

Quality of Life after Gene Therapy in Pediatric Patients with Transfusion-Dependent β-Thalassemia and Their Family Caregivers: A Prospective Cohort Study

Zhexiang Kuang, Anni Wang, Xiao Yu, Jing Xu, Weiwei Wang, Chun Xu, Xintong He, Weiping Yuan, Jun Shi, Li Xu, Wenjun Xie

Blood (2024) 144 (Supplement 1): 7653.

https://doi.org/10.1182/blood-2024-200445

Published: 2024

Journal Articles

Association of Dietary Profiles and Nutritional Status Among Patients with Hematologic Diseases: A Prospective Cohort Study

Xiao Yu, Jingyu Zhao, Jing Xu, Liyun Li, Jin Dong, Weiping Yuan, Jun Shi, Zhexiang Kuang

Blood (2024) 144 (Supplement 1): 7905.

https://doi.org/10.1182/blood-2024-202945

Published: 2024

Journal Articles

Daratumumab Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia: A Pilot Trail

Zhen Gao, Hong Pan, Jinbo Huang, Xin Zhao, Lele Zhang, Weiwang Li, Jianping Li, Neng Nie, Jingyu Zhao, Liyun Li, Jing Xu, Xiao Yu, Zhexiang Kuang, Meili Ge, Liwei Fang, Jun Shi

Blood (2024) 144 (Supplement 1): 4029.

https://doi.org/10.1182/blood-2024-204858

Published: 2024

Journal Articles

Patient Journey Mapping Enhances Nursing Care in Patients with Hematologic Diseases

Zhexiang Kuang, Xiao Yu, Anni Wang, Jing Xu, Jingyu Zhao, Xinli Li, Guibin Wu, Weiping Yuan, Jun Shi, Li Xu, Wenjun Xie

Blood (2024) 144 (Supplement 1): 7555.

https://doi.org/10.1182/blood-2024-200424

Published: 2024

Journal Articles

Delayed Physical Growth and Related Factors in Pediatric Patients with Transfusion-Dependent Thalassemia

Jingyu Zhao, Xiao Yu, Jing Xu, Zhen Gao, Yanjie Liu, Anni Wang, Jin Dong, Weiping Yuan, Jun Shi, Zhexiang Kuang

Blood (2024) 144 (Supplement 1): 2307.

https://doi.org/10.1182/blood-2024-200683

Published: 2024

Journal Articles

Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas

Blood (2023) 142 (Supplement 1): 4458.

https://doi.org/10.1182/blood-2023-181385

Published: 2023

Journal Articles

KMT2D Deficiency Promotes Myeloid Leukemias through Regulating Ribosome Biogenesis

Jing Xu, Ailing Zhong, Chong Chen, Yu Liu, Ting Niu

Blood (2022) 140 (Supplement 1): 5855–5856.

https://doi.org/10.1182/blood-2022-168509

Published: 2022

Journal Articles

Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma

Alejandro Berkovits, Eduardo Yanez, Christine Rojas, Raimundo Gazitua, Nicolás Cazap, Anna Sureda, Rao Saleem, Robin Meng, Jing Xu, Michael Streit, Valentine Barboux, Sairah Ahmed

Blood (2022) 140 (Supplement 1): 12020–12021.

https://doi.org/10.1182/blood-2022-159980

Published: 2022

Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Blood (2022) 140 (Supplement 1): 10652–10653.

https://doi.org/10.1182/blood-2022-166365

Published: 2022

Journal Articles

Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma

Stephan M Tirier, PhD, Jan-Philipp Mallm, PhD, Nicola Casiraghi, PhD, Hana Susak, PhD, Nicola Giesen, MD, Alexandra M Poos, PhD, Katharina Bauer, Anja Baumann, Lukas John, MD, Jing Xu, PhD, Lara Klett, MSc, Carsten Müller-Tidow, MD, Benedikt Brors, PhD, Hartmut Goldschmidt, MD, Niels Weinhold, PhD, Oliver Stegle, PhD, Karsten Rippe, PhD, Marc S. Raab, MD

Blood (2019) 134 (Supplement_1): 571.

https://doi.org/10.1182/blood-2019-128625

Published: 2019

Journal Articles

A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma

Blood (2019) 134 (Supplement_1): 575.

https://doi.org/10.1182/blood-2019-130051

Published: 2019

Journal Articles

Biallelic Inactivation of Multiple Tumor Suppressors Is Associated with Early Relapse after Stem Cell Transplant in Newly Diagnosed Myeloma

Niels Weinhold, PhD, Jing Xu, PhD, Martina Fröhlich, PhD, Alexandra M Poos, PhD, Lukas John, MD, Carsten Müller-Tidow, MD, Sandra Sauer, MD, Stefanie Huhn, PhD, Dirk Hose, MD, Anja Seckinger, Kari Hemminki, MD PhD, Benedikt Brors, PhD, Hartmut Goldschmidt, MD, Nicola Giesen, MD, Marc S Raab, MD PhD

Blood (2019) 134 (Supplement_1): 1783.

https://doi.org/10.1182/blood-2019-131195

Published: 2019

Journal Articles

Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib

Moshe Yair Levy, MD, Lin Xie, MA, MS, Yuexi Wang, Frank Neumann, MD PhD, Shouryadeep Srivastava, MBBS, PhD, Daniel Naranjo, Jing Xu, Qisu Zhang, MPH, Mehul Dalal, PhD

Blood (2019) 134 (Supplement_1): 4751.

https://doi.org/10.1182/blood-2019-129053

Published: 2019

Journal Articles

mTOR Signal Pathway Inhibition Promote the Cytotoxicity of Chemotherapy on SHI-1 Cells

Jing Xu, Zhenjiang Li, Jifu Zheng, Qiong Wu, Qingming Wang, Aiping Tang, Yuan Song, Yan Fei

Blood (2019) 134 (Supplement_1): 5126.

https://doi.org/10.1182/blood-2019-126714

Published: 2019

Journal Articles

Spectrum of Gene Mutations and Clinical Significance in Myeloid Malignancies Patients with ASXL1 Mutations

Jie Bai, MD, Guangshuai Teng, Yingshao Wang, Jing Xu, Chenxiao Du, Yan Wang, Yafang Chen, Mengyao Sheng, PhD, Jiaojiao Bai, Lei Zhang, MD, Yuan Zhou, PhD, Feng-Chun Yang, MD PhD

Blood (2018) 132 (Supplement 1): 3906.

https://doi.org/10.1182/blood-2018-99-114471

Published: 2018

Journal Articles

Rapamycin Promote the Inhibition Rate of Proliferation on SHI-1 Cells and Enhance the Efficacy of Chemotherapy in Npg Leukemia Mice

Jing Xu, Zhenjiang Li, Jifu Zheng, Qiong Wu, Qingming Wang, Aiping Tang, Yuan Song, Yan Fei

Blood (2018) 132 (Supplement 1): 5217.

https://doi.org/10.1182/blood-2018-99-112877

Published: 2018

Journal Articles

Establishment of Human Acute Monocyte Leukemia Model with Systemic Leukemia in Npg Mice

Jing Xu, Zhenjiang Li, Qiong Wu, Wenfeng He, Jifu Zheng, Qingming Wang, Aiping Tang, Wanlei Sun, Yanfei Rao

Blood (2018) 132 (Supplement 1): 4041.

https://doi.org/10.1182/blood-2018-99-112395

Published: 2018

Journal Articles

KMT2D Is a Haploinsufficient Tumor Suppressor in Acute Leukemia

Jing Xu, MD, Yu Liu, PhD, Chong Chen, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 1511.

https://doi.org/10.1182/blood-2018-99-119038

Published: 2018

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Deciphering Hematopoietic Reconstitution Dynamics of Lentiviral Vector HBB T87Q -Engineered Hematopoietic Stem Cells Gene Therapy for β-Thalassemia Patients

Quality of Life after Gene Therapy in Pediatric Patients with Transfusion-Dependent β-Thalassemia and Their Family Caregivers: A Prospective Cohort Study

Association of Dietary Profiles and Nutritional Status Among Patients with Hematologic Diseases: A Prospective Cohort Study

Daratumumab Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia: A Pilot Trail

Patient Journey Mapping Enhances Nursing Care in Patients with Hematologic Diseases

Delayed Physical Growth and Related Factors in Pediatric Patients with Transfusion-Dependent Thalassemia

Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas

KMT2D Deficiency Promotes Myeloid Leukemias through Regulating Ribosome Biogenesis

Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma

A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma

Biallelic Inactivation of Multiple Tumor Suppressors Is Associated with Early Relapse after Stem Cell Transplant in Newly Diagnosed Myeloma

Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib

mTOR Signal Pathway Inhibition Promote the Cytotoxicity of Chemotherapy on SHI-1 Cells

Spectrum of Gene Mutations and Clinical Significance in Myeloid Malignancies Patients with ASXL1 Mutations

Rapamycin Promote the Inhibition Rate of Proliferation on SHI-1 Cells and Enhance the Efficacy of Chemotherapy in Npg Leukemia Mice

Establishment of Human Acute Monocyte Leukemia Model with Systemic Leukemia in Npg Mice

KMT2D Is a Haploinsufficient Tumor Suppressor in Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only